Although this has not been confirmed in humans, GLP-1 medications are generally not recommended for individuals with: A personal or family history of medullary thyroid cancer Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) A complete medical evaluation is required before starting therapy
Increase to 0.75mg (0.15mL) for three additional trials before moving to 1.0mg (0.2mL)
Effects of L-carnitine supplementation on respiratory distress syndrome development and prognosis in premature infants: a single blind randomized controlled trial
Always consult a qualified health professional to assess the need, correct amounts, and risks involved in supplementation
Direct Cardiac Effects: GLP-1 receptors exist in the heart, potentially influencing pacemaker activity or conduction pathways
In a few months, the worlds KTP braintrust will meet in Alicante, Spain, for Kolor, the first world congress on eye color change